Activities per year
Activities
- 1 - 50 out of 57 results
Search results
-
NAFLD
Jesper Bøje Andersen (Invited speaker)
24 Nov 2017Activity: Talk or presentation types › Lecture and oral contribution
-
ILCA: Molecular classification and key drivers of intrahepatic CCA
Jesper Bøje Andersen (Invited speaker)
Sep 2017Activity: Talk or presentation types › Lecture and oral contribution
-
Chair: Liver cancer session
Jesper Bøje Andersen (Panel member)
Sep 2017Activity: Talk or presentation types › Lecture and oral contribution
-
Riccardo Cortese memorial lecture
Jesper Bøje Andersen (Invited speaker)
Jul 2017Activity: Talk or presentation types › Lecture and oral contribution
-
Korean liver week
Jesper Bøje Andersen (Invited speaker)
Jun 2017Activity: Talk or presentation types › Lecture and oral contribution
-
BioPeople: Future of Oncology Biomarkers Seminar & Biomed
Jesper Bøje Andersen (Panel member)
May 2017Activity: Talk or presentation types › Lecture and oral contribution
-
University of Mainz, Medicine 1: Liver lunch
Jesper Bøje Andersen (Invited speaker)
28 Mar 2017Activity: Talk or presentation types › Lecture and oral contribution
-
Satorius Research Xchange Forum: Insights, Translation and Solutions
Jesper Bøje Andersen (Invited speaker)
21 Feb 2017 → 23 Feb 2017Activity: Talk or presentation types › Lecture and oral contribution
-
Hepatology (Journal)
Jesper Bøje Andersen (Member of Editorial Board)
1 Feb 2017 → …Activity: Peer-review and editorial work types › Editor of Research journal › Research
-
The Cancer Genome Atlas: pan-TGFb Network (External organisation)
Jesper Bøje Andersen (Member)
2017Activity: Membership types › Membership in research network
-
The Cancer Genome Atlas: Tumor Molecular Pathology (TMP) Analysis Working Group (External organisation)
Jesper Bøje Andersen (Member)
2017Activity: Membership types › Membership in research network
-
Liver Cancer Seminar Series
Jesper Bøje Andersen (Invited speaker)
1 Dec 2016Activity: Talk or presentation types › Lecture and oral contribution
-
European Network Study for Cholangiocarcinoma: 1st International monothematic congress in cholangiocarcinoma: Molecular pathogenesis of intrahepatic cholangiocarcinoma
Jesper Bøje Andersen (Invited speaker)
4 May 2016 → 6 May 2016Activity: Talk or presentation types › Lecture and oral contribution
-
Center for Excellence and Integrative Cancer Biology and Genomics, NIH
Jesper Bøje Andersen (Invited speaker)
17 Mar 2016 → 18 Mar 2016Activity: Talk or presentation types › Lecture and oral contribution
-
4th Symposium on Translational Genomics with a Special Focus on Liver
Jesper Bøje Andersen (Invited speaker)
Mar 2016Activity: Talk or presentation types › Lecture and oral contribution
-
Cholangiocarcinoma Foundation Congress: Translational genomics: Application of murine models for understanding tumor heterogeneity
Jesper Bøje Andersen (Invited speaker)
3 Feb 2016 → 6 Feb 2016Activity: Talk or presentation types › Lecture and oral contribution
-
Mutagen-Brazil: Translational Research
Jesper Bøje Andersen (Invited speaker)
28 Jan 2016 → 30 Jan 2016Activity: Talk or presentation types › Lecture and oral contribution
-
International Journal of Rare Diseases & Orphan Drugs (Journal)
Jesper Bøje Andersen (Member of Editorial Board)
2016 → …Activity: Peer-review and editorial work types › Editor of Research journal › Research
-
Highlight from Hepatology 2015: From Chronic Hepatitis to HCC: Molecular pathogenesis and current therapy in intrahepatic cholangiocarcinoma
Jesper Bøje Andersen (Invited speaker)
Oct 2015Activity: Talk or presentation types › Lecture and oral contribution
-
Molecular pathogenesis of cholangiocarcinoma
Jesper Bøje Andersen (Lecturer)
Oct 2015Activity: Talk or presentation types › Lecture and oral contribution
-
Hepatobiliary cancers: Translational Genomics Directs Therapeutic Options
Jesper Bøje Andersen (Invited speaker)
Aug 2015Activity: Talk or presentation types › Lecture and oral contribution
-
EU-Life: Epigenetics and Disease
Jesper Bøje Andersen (Organizer)
11 May 2015 → 13 May 2015Activity: Participating in an event - types › Organisation of and participation in conference
-
European Network Study for Cholangiocarcinoma: ENS-CCA (External organisation)
Jesper Bøje Andersen (Board member)
Apr 2015Activity: Membership types › Membership in research network
-
Hallas-Møller Fellowship
Jesper Bøje Andersen (Other)
Apr 2015Activity: Talk or presentation types › Lecture and oral contribution
-
BRIC-Lund University Retreat
Jesper Bøje Andersen (Speaker)
2015Activity: Talk or presentation types › Lecture and oral contribution
-
Nature Genetics (Journal)
Jesper Bøje Andersen (Review editor)
2015Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
-
ILCA: Decoding Tumor Heterogeneity Informs Targeted Therapies in Intrahepatic Cholangiocarcinoma
Jesper Bøje Andersen (Speaker)
4 Sep 2014Activity: Talk or presentation types › Lecture and oral contribution
-
Molecular Classification of Cholangiocarcinoma and Therapeutic Implications
Jesper Bøje Andersen (Invited speaker)
9 May 2014Activity: Talk or presentation types › Lecture and oral contribution
-
Eu-Life: Translational Working Group (External organisation)
Jesper Bøje Andersen (Member)
2014Activity: Membership types › Membership in committee, council, board
-
The Cancer Genome Atlas (TCGA), Cholangiocarcinoma Analysis Working Group (External organisation)
Jesper Bøje Andersen (Member)
2014 → …Activity: Membership types › Membership in research network
-
Emerging Targets in the treatment of Cholangiocarcinoma: Liver cancer seminar
Jesper Bøje Andersen (Lecturer)
20 Nov 2013Activity: Talk or presentation types › Lecture and oral contribution
-
Gut, Molecular Carcinogenesis, Oncogene (Journal)
Jesper Bøje Andersen (Review editor)
2013Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
-
ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma
Jesper Bøje Andersen (Speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
-
Georgetown University, Lombardi Comprehensive Cancer Center: Emerging Genomics-based Targets in the treatment of Cholangiocarcinoma: Ruesch symposium on HCC
Jesper Bøje Andersen (Invited speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
-
Bench to Bedside: New Directions for Therapy in Primary Liver Cancer: Cancer Biology Symposium
Jesper Bøje Andersen (Invited speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
-
Bench to Bedside: Translational genomics identifies promising targeted therapy for cholangiocarcinoma: Humanitas Fondazione per la Ricerca Seminars
Jesper Bøje Andersen (Lecturer)
2013Activity: Talk or presentation types › Lecture and oral contribution
-
The Italian chapter of the International Cholangiocarcinoma Network (External organisation)
Jesper Bøje Andersen (Member)
2013Activity: Membership types › Membership in research network
-
AASLD: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma.: Experimental Hepatocarcinogenesis
Jesper Bøje Andersen (Speaker)
2013Activity: Talk or presentation types › Lecture and oral contribution
-
British Journal of Cancer; Journal of Cancer Therapeutics & Research, BMC Cancer; Cancer Research; Clinical Cancer Research; PLoS ONE (Journal)
Jesper Bøje Andersen (Review editor)
2012Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
-
ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma
Jesper Bøje Andersen (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
-
The Hepatobiliary Cancers Foundation (CanLiv): Genomic Basis for Targeted Therapies in Cholangiocarcinoma
Jesper Bøje Andersen (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
-
Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy
Jesper Bøje Andersen (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
-
ILCA: Application of Translational Genomics for Targeted Therapy in Cholangiocarcinoma
Jesper Bøje Andersen (Speaker)
2012Activity: Talk or presentation types › Lecture and oral contribution
-
Gastroenterology; Liver Transplantation; Clinical Gastroenterology & Hepatology (Journal)
Jesper Bøje Andersen (Review editor)
2011Activity: Peer-review and editorial work types › Peer review of manuscripts › Research
-
Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors
Jesper Bøje Andersen (Speaker)
2011Activity: Talk or presentation types › Lecture and oral contribution
-
ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors
Jesper Bøje Andersen (Speaker)
2011Activity: Talk or presentation types › Lecture and oral contribution
-
International Liver Cancer Association (ILCA) (External organisation)
Jesper Bøje Andersen (Member)
2010Activity: Membership types › Membership in research network
-
ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma
Jesper Bøje Andersen (Speaker)
2010Activity: Talk or presentation types › Lecture and oral contribution
-
ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer
Jesper Bøje Andersen (Speaker)
2009Activity: Talk or presentation types › Lecture and oral contribution
-
EASL: Modulation of Demethylation and Antitumor Potential of Zebularine in Liver Cancer
Jesper Bøje Andersen (Speaker)
2009Activity: Talk or presentation types › Lecture and oral contribution